secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunovant, Inc. (IMVT)
CIK:        0001764013
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0001764013-22-000143
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunovant presents at LifeSci Capital fireside chat; no material details disclosed
--------------------------------------------------------------------------------

- Immunovant participated in a virtual fireside chat hosted by LifeSci Capital on December 8, 2022.
- A presentation was furnished as Exhibit 99.1 and incorporated by reference.
- No specific financial or pipeline data from the presentation is included in the filing text provided.
- The presentation was posted for investors, but its substantive content is not available in this summary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764013/000176401322000143/0001764013-22-000143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764013/000176401322000143/imvt-20221208.htm
  HTML page:      https://secwatch.observer/filing/0001764013-22-000143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer